Previous 10 | Next 10 |
SAN CARLOS, Calif. , March 26, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will partner with AMAL Therapeutics on a clinical trial focused on stage IV colorectal cancer. This study adds to the growing number of pharmaceutical tri...
Deals and Financings InventisBio of Shanghai closed a $70 million Series C financing co-led by Advantech Capital and CMBI, followed by Pudong Innotek (see story ). Founded in 2013, InventisBio focuses on discovering and developing novel therapeutics for cancer and metabolic diseases. The co...
The following slide deck was published by Natera, Inc. in conjunction with their 2018 Q4 earnings Read more ...
Natera Inc. (NASDAQ:NTRA) shares are soaring up +20% this morning after the healthcare company released its Q4 and full 2018 earnings. The healthcare stock is seeing its biggest share rise today in well over six months. Investors seem pleased with Natera’s earnings, so if youȁ...
Gainers: Akari Therapeutics (NASDAQ: AKTX ) +177% . Pareteum Corporation (NASDAQ: TEUM ) +26% . Clean Energy Fuels (NASDAQ: CLNE ) +25% . Guardant Health (NASDAQ: GH ) +24% . Vera Bradley (NASDAQ: VRA ) +21% . Natera (NASDAQ: NTRA ) +20% . Conatus Pharmaceuticals (NASDAQ: CNAT ...
Natera, Inc. (NTRA) Q4 2018 Earnings Conference Call March 12, 2019, 04:00 PM ET Company Participants Steve Chapman - CEO Mike Brophy - CFO Bob Schueren – COO Solomon Moshkevich - SVP, Product and Strategy Matt Rabinowitz - Executive Chairman Conference Call Partici...
Gainers: CLNE +11.1% . CARA +10.4% . NTRA +8.3% . EYPT +7.8% . LPTX +7.5% . More news on: Clean Energy Fuels Corp., Cara Therapeutics, Inc., Natera, Inc., Stocks on the move, Read more ...
Natera (NASDAQ: NTRA ): Q4 GAAP EPS of -$0.51 in-line. More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN CARLOS, Calif. , March 12, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the fourth quarter and year ended December 31, 2018 , and provided...
SAN CARLOS, Calif. and SHENZHEN, China , March 11, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., (300676.SZ), the largest cell-free DNA clinical testing laboratory in China and one of the...
News, Short Squeeze, Breakout and More Instantly...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-13 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...